West Pharma amends credit facility to $500M, extends to 2027; adds Japanese subsidiary as borrower

WEST PHARMACEUTICAL SERVICES INC

Increased credit facility from $300M to $500M senior unsecured revolving; maturity extended to March 31, 2027.
Added West Pharmaceutical Services Holding Japan Godo Kaisha as additional borrower under the facility.
Interest: Term SOFR + 0.10% + margin of 87.5-137.5 bps or base rate + 0-37.5 bps.
Financial covenant: Net Consolidated Debt to modified EBITDA ratio max 3.5:1 (4.0:1 for qualified acquisitions up to 4 quarters).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.